Together, Outsmarting Prostate Cancer

As you may know, one out of every six men will develop prostate cancer in their lifetime, and around 27,000 die of the disease in the U.S. each year.

But what if prostate cancer could be…

  • targeted with tailor-made therapies and vaccines?
  • treated more like a chronic disease?
  • or – eradicated in its initial stages so it never spreads?

Discoveries by our cancer researchers and specialists are already resulting in longer, healthier lives for many patients.

With your generosity we can rapidly transform this deadly cancer from a life-threatening diagnosis into a preventable, treatable condition. Will you help us outsmart cancer?

You Can Help Us Outsmart Prostate Cancer

Give today

Your Impact

Thanks to generous donors like you, we have:

Identified and/or assembled up to 80 percent of the genes expressed in prostate cancer, which will aid in drug development.

Characterized inherited mutations that make men more susceptible to the diagnosis of prostate cancer, affecting screening and treatment.

Assembled information and genotypes for more than 300 families with hereditary prostate cancer, helping us to develop targeted therapies for these cancers.

Developed new therapeutics that result in fewer side effects and better quality of life.

The Path to Outsmarting Prostate Cancer

World-renowned investigators at the Institute for Prostate Cancer Research (IPCR), a UW Medicine and Fred Hutch collaboration, are involved in landscape-changing research across the spectrum of prostate cancer. Your generosity powers the expert team of scientists and clinicians at IPCR whose mission it is to understand prostate cancer, to devise therapies and new technologies, and — one day — to find a cure.

Your support propels urgently needed research to understand prostate cancer causes and progression, develop new prevention methods, devise innovative diagnostics and improve survival and quality of life.

A Smart Investment in
Cancer Research, Care and Education

Your support helps us outsmart cancer, including prostate cancer, by accelerating promising research, providing exceptional care and training the next generation of cancer specialists.

What makes us a smart investment?


UW Medicine brings together our region’s top cancer researchers and specialists in multidisciplinary teams to care for patients and collaborate on cutting-edge research. We are proud partners of the Seattle Cancer Care Alliance, along with Fred Hutchinson Cancer Research Center and Seattle Children’s. And, as a leading academic research institution, we share the latest discoveries with the broader medical community to help patients worldwide.


Our patients are benefiting today from the cancer treatments of tomorrow. Because we do both research and patient care, we can rapidly apply the latest discoveries in cancer research to help our patients live better, longer, healthier lives.


We’re addressing the systemic inequities that increase cancer risk and mortality among underserved communities. This includes research on disproportionate cancer mortality rates and projects to increase cancer screening in underserved populations.


Prostate cancer survivor Patrick Carr
Screening can catch prostate cancer early
Chris Carr went in for a routine wellness check when his primary care provider noticed something was off with his blood test results. Now, Carr’s sharing his story to get his important message out there: get screened.
Watch now>>

Illustration of male and female DNA and a family tree
Cancer’s family tree
Did you know that you can inherit prostate cancer from your mother?
Read more>>

Blood cell mutations confound prostate cancer liquid biopsy
False-positive results – and incorrect treatment – can occur when specific mutations, unrelated to cancer, are present in blood plasma.
Read more>>

Join Us

Prostate cancer doesn’t have to be a life-threatening disease. Our scientists and clinicians are hard at work to discover new mechanisms, novel drugs, and ultimate cures for prostate cancer. But they can’t do it without your generous and visionary support.

Learn more about our work in other cancer specialties or contact us with questions at 206.543.5686 or